Heparin News and Research

RSS
Heparin, a highly-sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machines. Pharmaceutical grade heparin is derived from mucosal tissues of slaughtered meat animals such as porcine (pig) intestine or bovine (cow) lung.
Pixatimod is active in lab studies against SARS-CoV-2

Pixatimod is active in lab studies against SARS-CoV-2

Researchers find prothrombotic antibodies in patients with COVID-19

Researchers find prothrombotic antibodies in patients with COVID-19

Severity of COVID-19 linked to heparanase activity and heparan sulfate levels

Severity of COVID-19 linked to heparanase activity and heparan sulfate levels

Anticardiolipin antibodies and COVID-19

Anticardiolipin antibodies and COVID-19

Blood clotting disorders may explain some of the worst symptoms of COVID-19

Blood clotting disorders may explain some of the worst symptoms of COVID-19

Heparin resistance among COVID-19 patients admitted to ICU

Heparin resistance among COVID-19 patients admitted to ICU

Heparin may stop SARS-CoV-2 infecting host cells

Heparin may stop SARS-CoV-2 infecting host cells

Immunotherapy, steroids restore heart function in children with COVID-related multi-system inflammatory syndrome

Immunotherapy, steroids restore heart function in children with COVID-related multi-system inflammatory syndrome

The use of rheumatoid arthritis drug sarilumab in severe COVID-19 pneumonia

The use of rheumatoid arthritis drug sarilumab in severe COVID-19 pneumonia

Steroids and immunotherapy improve outcomes in children with COVID-related multi-system inflammatory syndrome

Steroids and immunotherapy improve outcomes in children with COVID-related multi-system inflammatory syndrome

SARS-CoV-2 binds heparan sulfate, preventing host cell infection

SARS-CoV-2 binds heparan sulfate, preventing host cell infection

Treating hospitalized COVID-19 patients with anticoagulants may improve their survival chances

Treating hospitalized COVID-19 patients with anticoagulants may improve their survival chances

Cytokine storms created by COVID-19 could be reduced by using blood filter

Cytokine storms created by COVID-19 could be reduced by using blood filter

Study reveals antiviral properties of glycosaminoglycans against SARS-CoV-2

Study reveals antiviral properties of glycosaminoglycans against SARS-CoV-2

Low molecular weight heparins inhibit SARS-CoV-2 cell invasion

Low molecular weight heparins inhibit SARS-CoV-2 cell invasion

Rice University looks to ‘trap and zap’ SARS-CoV-2 in wastewater

Rice University looks to ‘trap and zap’ SARS-CoV-2 in wastewater

Early Heparin therapy improves hypoxia in COVID-19 patients

Early Heparin therapy improves hypoxia in COVID-19 patients

New report highlights blood clot dangers in patients with COVID-19

New report highlights blood clot dangers in patients with COVID-19

Direct oral anticoagulant more effective in lowering risk of VTE after common orthopedic surgeries

Direct oral anticoagulant more effective in lowering risk of VTE after common orthopedic surgeries

Oral apixaban as effective as dalteparin for treating blood clots in people with cancer

Oral apixaban as effective as dalteparin for treating blood clots in people with cancer